Glimepiride

格列美脲

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGlimepiride
Drug Alias Name格列美吡拉glimepiridaglimepiridumAmarilAmarel +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKATP channels blockersSulfonylurea receptor modulators
TargetsSulfonylurea receptorKATP channels
Therapy Area/IndicationsDiabetes Mellitus, Type 2Heart Failure
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryNetherlands
Original Approved Date1995/06/20
Country/TerritoryCanadaUnited StatesPoland +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiNanjing Medical UniversityTianjin Medical University +[6] 
Inactive CompaniesTheracos IncMylan Pharmaceuticals IncTeva Pharmaceuticals Usa Inc +[5] 
Active IndicationsDiabetes Mellitus, Type 2Heart Failure
Inactive IndicationsN/A

Other Information

ATC CodeA10BB12
Related LinksWikipediaDrugBankKEGG